Announcements Trials
Browse Landscape

Status

Completed 8Unknown 6Terminated 1Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 135Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1

Interventions

Surveys and Questionnaires 39Blood Specimen Collection 23Specimen Handling 14Radiotherapy 12Surgical Procedures, Operative 10Magnetic Resonance Spectroscopy 10Interviews as Topic 10Observation 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Immune Checkpoint Inhibitors 5Biopsy 5ribociclib 4palbociclib 4lorlatinib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Magnetic Resonance Imaging 4Ipilimumab 4High-Throughput Nucleotide Sequencing 4Hepatectomy 4Echocardiography 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Lenalidomide × Clear all
NCT03106324 2025-11-24

A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

Celgene

Active not recruiting
911 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡